Synthesis of DTPA-attached estradiol derivative and determination of its radiopharmaceutical potential

被引:7
作者
Biber, FZ [1 ]
Unak, P
Enginar, H
Ertay, T
Medine, EI
Tasci, C
Durak, H
机构
[1] Ege Univ, Inst Nucl Sci, Dept Nucl Applicat, Izmir, Turkey
[2] Afyon Kocatepe Univ, Dept Chem, Afyon, Turkey
[3] Dokuz Eylul Univ, Fac Med, Dept Nucl Med, Izmir, Turkey
关键词
D O I
10.1007/s10967-005-0930-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An estrogen derivative, beta-estradiol or 1,3,5,(10)-estratriene-3,17 beta-diol) attached to diethylenetriamine pentaacetic acid (DTPA) was synthesized in six experimental steps. At the end of these steps, a DTPA-attached estradiol derivative called deoxy-demethyl homoestradiolyl-diethylenetriamine-pentaacetic acid (ESTDTPA) was obtained. The synthesized compounds were labeled with Tc-99m. Thin layer radio chromatography (TLRC) was used to determine radiochemical yields and stabilities.Structural investigations confirmed the structures. The labeling yield was satisfactory (about 95%), and Tc-99m-ESTDPTA was stable in neutral medium at room temperature for 5 hours. Biodistribution studies were performed on normal and DMBA-induced, tumor bearing female Albino Wistar rats. The activity per gram tissue was calculated, and time-activity curves were plotted. ESTDTPA uptake by uterus reached a level of 20.73% dose/g, showing a maximum within 5 minutes after injection. Ovary and breast showed similar biodistribution profiles. The kidneys, which are the primary organs of metabolism and excretion of estrogen, showed a high Tc-99m-ESTDTPA uptake. The imaging studies were performed on normal and tumor bearing female Albino Wistar rats using a Camstar XR/T gamma-camera. Gamma-scintigraphy studies showed that tumors could be well visualized in a few minutes and clearly differentiated from other organs, such as bladder and liver by 24 hours.
引用
收藏
页码:445 / 454
页数:10
相关论文
共 24 条
[1]   Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus [J].
Brandenberger, AW ;
Tee, MK ;
Lee, JY ;
Chao, V ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3509-3512
[2]  
CARMEN SD, 1996, NUCL MED BIOL, V23, P491
[3]   Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue [J].
Delpassand, ES ;
Yang, DJ ;
Wallace, S ;
Cherif, A ;
Quadri, SM ;
Price, J ;
Joubert, A ;
Inoue, T ;
Podoloff, DA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (06) :553-559
[4]   Synthesis of a 99mTc labeled estrogen-derivative and the determination of its radio pharmaceutical potential on rats [J].
Enginar, H ;
Unak, P ;
Lambrecht, FY ;
Biber, FZ .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2004, 260 (02) :339-349
[5]   An oestrogen-derivative labeled with 99mTc and its radiopharmaceutical potential [J].
Enginar, H ;
Ünak, P ;
Yurt, F ;
Biber, FZ .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2002, 251 (03) :473-479
[6]   Clinical significance of expression of estrogen receptor α and β mRNAs in ovarian cancers [J].
Fujimoto, J ;
Hirose, R ;
Sakaguchi, H ;
Tamaya, T .
ONCOLOGY, 2000, 58 (04) :334-341
[7]   Therapeutic potential of selective estrogen receptor modulators [J].
Gustafsson, JA .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :508-511
[8]   Evaluation of 17α-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands [J].
Hanson, RN ;
Lee, CY ;
Friel, C ;
Hughes, A ;
DeSombre, ER .
STEROIDS, 2003, 68 (02) :143-148
[9]  
HUGHES A, 1993, J NUCL MED, V34, P272
[10]   Potential technetium small molecule radiopharmaceuticals [J].
Jurisson, SS ;
Lydon, JD .
CHEMICAL REVIEWS, 1999, 99 (09) :2205-2218